These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1977070)

  • 1. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
    Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
    Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
    Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.
    Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A
    Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
    Li SJ; Sivam SP; McGinty JF; Jiang HK; Douglass J; Calavetta L; Hong JS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):403-8. PubMed ID: 2899169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR; McGinty JF; Young WS
    J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
    Sivam SP
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.
    Li S; Sivam SP; Hong JS
    Brain Res; 1986 Nov; 398(2):390-2. PubMed ID: 2879611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents.
    Mandel RJ; Wictorin K; Cenci MA; Björklund A
    Brain Res; 1992 Jun; 583(1-2):207-15. PubMed ID: 1504828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L; Nieoullon A
    Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
    Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.
    Warenycia MW; McKenzie GM
    J Neural Transm; 1987; 70(3-4):217-32. PubMed ID: 3119772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.